Who Can Participate?
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
Yes
Study Details
Full Title
NRG-CC013: A RANDOMIZED, MASKED, PLACEBO CONTROLLED, PHASE II TRIAL OF CONCURRENT CHEMORADIATION WITH BMX-001 IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CHEMORADIATION
Principal Investigator
Jared
Robbins
Protocol Number
PRO00117671
NCT ID
NCT06532279
Phase
II
Enrollment Status
Open to Enrollment